Janiczek Wealth Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $151K | Sell |
475
-7
| -1% | -$2.23K | 0.03% | 224 |
|
|
2024
Q1 | $111K | Buy |
482
+84
| +21% | +$19.3K | 0.02% | 270 |
|
|
2023
Q4 | $87.5K | Sell |
398
-3
| -0.7% | -$660 | 0.02% | 287 |
|
|
2023
Q3 | $90.6K | Sell |
401
-10
| -2% | -$2.26K | 0.02% | 260 |
|
|
2023
Q2 | $90.7K | Buy |
411
+35
| +9% | +$7.73K | 0.03% | 233 |
|
|
2023
Q1 | $86K | Sell |
376
-13
| -3% | -$2.97K | 0.02% | 239 |
|
|
2022
Q4 | $102K | Buy |
389
+13
| +3% | +$3.4K | 0.03% | 221 |
|
|
2022
Q3 | $77K | Sell |
376
-6
| -2% | -$1.23K | 0.03% | 245 |
|
|
2022
Q2 | $88K | Sell |
382
-14
| -4% | -$3.23K | 0.03% | 218 |
|
|
2022
Q1 | $71K | Sell |
396
-52
| -12% | -$9.32K | 0.02% | 254 |
|
|
2021
Q4 | $97K | Buy |
448
+12
| +3% | +$2.6K | 0.03% | 195 |
|
|
2021
Q3 | $80K | Buy |
436
+93
| +27% | +$17.1K | 0.03% | 208 |
|
|
2021
Q2 | $62K | Buy |
343
+5
| +1% | +$904 | 0.02% | 217 |
|
|
2021
Q1 | $57K | Buy |
338
+93
| +38% | +$15.7K | 0.02% | 211 |
|
|
2020
Q4 | $37K | Buy |
245
+217
| +775% | +$32.8K | 0.02% | 253 |
|
|
2020
Q3 | $3K | Buy |
+28
| New | +$3K | ﹤0.01% | 477 |
|